Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04263584
Title Copanlisib in Combination With Rituximab and CHOP Chemotherapy in Patients With Previously Untreated DLBCL (COPA-R-CHOP)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors University Hospital Muenster
Indications

diffuse large B-cell lymphoma

follicular lymphoma

B-cell lymphoma

Therapies

Copanlisib + Cyclophosphamide + Doxorubicin + Prednisolone + Rituximab + Vincristine Sulfate

Age Groups: adult | senior
Covered Countries DEU

Facility Status City State Zip Country Details
University Hospital RWTH Aachen Recruiting Aachen 52074 Germany Details
Klinikum-Bremen-Mitte Recruiting Bremen 28205 Germany Details
St.-Johannes-Hospital Dortmund Recruiting Dortmund 44137 Germany Details
Onkozentrum Dresden Recruiting Dresden 01127 Germany Details
University Hospital Halle Recruiting Halle (Saale) 06120 Germany Details
Westpfalz-Klinikum Recruiting Kaiserslautern 67655 Germany Details
ÜBAG MVZ Dr. Vehling-Kaiser GmbH Recruiting Landshut 84036 Germany Details
University Hospital Leipzig Recruiting Leipzig 04103 Germany Details
University Hospital Muenster Recruiting Muenster 48149 Germany Details
Hospital of the Ludwig-Maximilians-University (LMU) Munich Recruiting Munich 81377 Germany Details
Hospital Stuttgart - Stuttgart Cancer Center Recruiting Stuttgart 70174 Germany Details
University Hospital Ulm Recruiting Ulm 89081 Germany Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field